LXRX Annual Current Assets
$176.55 M
+$35.68 M+25.33%
31 December 2023
Summary:
As of January 23, 2025, LXRX annual total current assets is $176.55 million, with the most recent change of +$35.68 million (+25.33%) on December 31, 2023. During the last 3 years, it has risen by +$18.83 million (+11.94%). LXRX annual current assets is now -66.84% below its all-time high of $532.40 million, reached on December 31, 2015.LXRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Quarterly Current Assets
$268.61 M
-$52.24 M-16.28%
30 September 2024
Summary:
As of January 23, 2025, LXRX quarterly total current assets is $268.61 million, with the most recent change of -$52.24 million (-16.28%) on September 30, 2024. Over the past year, it has dropped by -$96.04 million (-26.34%). LXRX quarterly current assets is now -49.55% below its all-time high of $532.40 million, reached on December 31, 2015.LXRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.3% | -26.3% |
| 3 y3 years | +11.9% | +93.2% |
| 5 y5 years | +1.9% | -26.1% |
LXRX Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.5% | -26.3% | +313.9% |
| 5 y | 5-year | -47.7% | +98.5% | -26.3% | +313.9% |
| alltime | all time | -66.8% | +1298.5% | -49.5% | +2522.4% |
Lexicon Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $268.61 M(-16.3%) |
| June 2024 | - | $320.84 M(-12.0%) |
| Mar 2024 | - | $364.65 M(+106.5%) |
| Dec 2023 | $52.88 M(-1.0%) | $176.55 M(-21.0%) |
| Sept 2023 | - | $223.37 M(-15.3%) |
| June 2023 | - | $263.72 M(+140.7%) |
| Mar 2023 | - | $109.55 M(-22.2%) |
| Dec 2022 | $53.43 M(+11.3%) | $140.87 M(+1.3%) |
| Sept 2022 | - | $139.06 M(+114.3%) |
| June 2022 | - | $64.90 M(-26.6%) |
| Mar 2022 | - | $88.43 M(-0.6%) |
| Dec 2021 | $47.99 M(+4.2%) | $88.92 M(-28.3%) |
| Sept 2021 | - | $124.00 M(+0.6%) |
| June 2021 | - | $123.26 M(-15.2%) |
| Mar 2021 | - | $145.42 M(-7.8%) |
| Dec 2020 | $46.07 M(-42.4%) | $157.72 M(+29.3%) |
| Sept 2020 | - | $121.94 M(-50.5%) |
| June 2020 | - | $246.19 M(-15.6%) |
| Mar 2020 | - | $291.61 M(-13.7%) |
| Dec 2019 | $79.96 M(-27.8%) | $337.75 M(-7.1%) |
| Sept 2019 | - | $363.59 M(+196.9%) |
| June 2019 | - | $122.46 M(-16.6%) |
| Mar 2019 | - | $146.83 M(-15.3%) |
| Dec 2018 | $110.81 M(-3.3%) | $173.32 M(-12.6%) |
| Sept 2018 | - | $198.36 M(-9.9%) |
| June 2018 | - | $220.19 M(-19.4%) |
| Mar 2018 | - | $273.15 M(-15.2%) |
| Dec 2017 | $114.54 M(-2.7%) | $322.00 M(+50.5%) |
| Sept 2017 | - | $214.02 M(-13.4%) |
| June 2017 | - | $247.19 M(-11.4%) |
| Mar 2017 | - | $279.09 M(-22.0%) |
| Dec 2016 | $117.75 M(-1.5%) | $357.87 M(-10.2%) |
| Sept 2016 | - | $398.74 M(-9.3%) |
| June 2016 | - | $439.45 M(-10.7%) |
| Mar 2016 | - | $492.16 M(-7.6%) |
| Dec 2015 | $119.56 M(+16.8%) | $532.40 M(+84.3%) |
| Sept 2015 | - | $288.95 M(-7.9%) |
| June 2015 | - | $313.80 M(-8.3%) |
| Mar 2015 | - | $342.31 M(-7.2%) |
| Dec 2014 | $102.39 M(-26.7%) | $368.99 M(+320.2%) |
| Sept 2014 | - | $87.82 M(+1.3%) |
| June 2014 | - | $86.67 M(-17.8%) |
| Mar 2014 | - | $105.41 M(-21.7%) |
| Dec 2013 | $139.61 M(-0.9%) | $134.55 M(-15.6%) |
| Sept 2013 | - | $159.36 M(-13.0%) |
| June 2013 | - | $183.08 M(-11.3%) |
| Mar 2013 | - | $206.46 M(-10.6%) |
| Dec 2012 | $140.84 M | $230.94 M(+6.9%) |
| Sept 2012 | - | $216.09 M(-9.3%) |
| June 2012 | - | $238.28 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $258.99 M(-9.4%) |
| Dec 2011 | $144.72 M(-4.9%) | $285.79 M(+91.8%) |
| Sept 2011 | - | $148.98 M(-11.9%) |
| June 2011 | - | $169.19 M(-12.4%) |
| Mar 2011 | - | $193.19 M(-10.0%) |
| Dec 2010 | $152.15 M(+72.7%) | $214.74 M(-8.9%) |
| Sept 2010 | - | $235.62 M(-16.6%) |
| June 2010 | - | $282.45 M(-12.3%) |
| Mar 2010 | - | $321.91 M(+89.7%) |
| Dec 2009 | $88.08 M(-42.2%) | $169.68 M(+26.9%) |
| Sept 2009 | - | $133.71 M(+39.4%) |
| June 2009 | - | $95.95 M(+1.8%) |
| Mar 2009 | - | $94.22 M(-13.7%) |
| Dec 2008 | $152.34 M(+45.6%) | $109.17 M(-16.9%) |
| Sept 2008 | - | $131.43 M(-14.1%) |
| June 2008 | - | $152.95 M(-12.3%) |
| Mar 2008 | - | $174.38 M(-34.1%) |
| Dec 2007 | $104.65 M(-0.1%) | $264.65 M(-5.3%) |
| Sept 2007 | - | $279.40 M(+178.6%) |
| June 2007 | - | $100.28 M(+54.8%) |
| Mar 2007 | - | $64.78 M(-24.3%) |
| Dec 2006 | $104.71 M(-7.1%) | $85.55 M(+46.4%) |
| Sept 2006 | - | $58.44 M(-20.9%) |
| June 2006 | - | $73.86 M(-20.2%) |
| Mar 2006 | - | $92.58 M(-12.7%) |
| Dec 2005 | $112.67 M(-0.5%) | $106.05 M(+11.2%) |
| Sept 2005 | - | $95.37 M(+22.1%) |
| June 2005 | - | $78.11 M(+3.4%) |
| Mar 2005 | - | $75.57 M(-23.5%) |
| Dec 2004 | $113.23 M(+0.5%) | $98.75 M(-4.8%) |
| Sept 2004 | - | $103.70 M(-5.8%) |
| June 2004 | - | $110.05 M(-27.6%) |
| Mar 2004 | - | $152.05 M(-11.3%) |
| Dec 2003 | $112.69 M(+64.2%) | $171.50 M(+17.0%) |
| Sept 2003 | - | $146.64 M(+34.1%) |
| June 2003 | - | $109.34 M(-5.7%) |
| Mar 2003 | - | $115.99 M(-12.9%) |
| Dec 2002 | $68.64 M(-6.7%) | $133.13 M(+6.9%) |
| Sept 2002 | - | $124.52 M(-10.8%) |
| June 2002 | - | $139.55 M(-6.4%) |
| Mar 2002 | - | $149.09 M(-10.4%) |
| Dec 2001 | $73.55 M(+401.7%) | $166.44 M(-12.5%) |
| Sept 2001 | - | $190.29 M(-6.5%) |
| June 2001 | - | $203.52 M(+2.6%) |
| Mar 2001 | - | $198.35 M(-3.7%) |
| Dec 2000 | $14.66 M(+51.6%) | $206.03 M(-1.3%) |
| Sept 2000 | - | $208.74 M(-1.6%) |
| June 2000 | - | $212.16 M(+1971.4%) |
| Mar 2000 | - | $10.24 M |
| Dec 1999 | $9.67 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual current assets year-on-year change?
- What is Lexicon Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly current assets year-on-year change?
What is Lexicon Pharmaceuticals annual total current assets?
The current annual current assets of LXRX is $176.55 M
What is the all time high annual current assets for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual total current assets is $532.40 M
What is Lexicon Pharmaceuticals annual current assets year-on-year change?
Over the past year, LXRX annual total current assets has changed by +$35.68 M (+25.33%)
What is Lexicon Pharmaceuticals quarterly total current assets?
The current quarterly current assets of LXRX is $268.61 M
What is the all time high quarterly current assets for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly total current assets is $532.40 M
What is Lexicon Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, LXRX quarterly total current assets has changed by -$96.04 M (-26.34%)